alexa Proteoglycomics and Disease Marker: Promises and Future
ISSN: 2379-1764

Advanced Techniques in Biology & Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Proteoglycomics and Disease Marker: Promises and Future Challenges



Proteoglycomics is a systematic study of structure, expression, and function of proteoglycans, post-translationally modified subset of proteome. The process of glycan synthesis relies on number of highly competitive process involving glycosyl tranferases. Therefore, the process of glycosylation is highly sensitive to biochemical environment and has been implicated in many diseases including cancer. Recently, the interest in profiling glycome has increased for the potential of glycan as disease marker. The established technologies of proteomics and glycomics, proteoglycomics research requires unique approaches for elucidating structure-function relationship of proteoglycan components, glycosaminoglycans chain and core protein. This review discuss on the existing newly developed technologies widely involved in profiling glycome and role of proteoglycans that can be used as potential marker for disease condition.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version